Radiation oncology firm Nucletron of Veenendaal, Netherlands, enjoyed strong financial results over the first half of 2009.
Net sales amounted to $73.1 million (51.2 million euros), a 3% increase compared to the first half of 2008. Nucletron attributed the results in part to its collaboration with Advanced Radiation Therapy of Billerica, MA, and Isodose Control of Ede, Netherlands.
Related Reading
Nucletron outfits US Oncology, July 24, 2009
Nucletron adds executives, July 21, 2009
Nucletron nets FDA OK for new apps, July 13, 2009
Elekta, Nucletron ink Mosaiq deal, May 19, 2009
Nucletron adds to sales in 2008, April 24, 2009
Copyright © 2009 AuntMinnie.com